766539-28-0 Usage
General Description
2-Carbomethyl-morpholine-4-carboxylic Acid Tert-Butyl Ester is a chemical compound potentially used in various scientific and industrial applications. Because it's not naturally occurring, it is synthesized in a lab. The compound itself can be classified under the broader group of Morpholines. Morpholines are commonly used in chemical synthesis because of their versatility. As a specific morpholine derivative, the 2-Carbomethyl-morpholine-4-carboxylic Acid Tert-Butyl Ester could be used in the development of pharmaceuticals or other chemical products. Its chemical properties such as its reactivity, stability, and implications for health and safety would be determined through rigorous testing processes in laboratory settings.
Check Digit Verification of cas no
The CAS Registry Mumber 766539-28-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,6,5,3 and 9 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 766539-28:
(8*7)+(7*6)+(6*6)+(5*5)+(4*3)+(3*9)+(2*2)+(1*8)=210
210 % 10 = 0
So 766539-28-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H19NO5/c1-11(2,3)17-10(15)12-4-5-16-8(7-12)6-9(13)14/h8H,4-7H2,1-3H3,(H,13,14)
766539-28-0Relevant articles and documents
Novel anticancer compound and usage thereof
-
Paragraph 0032; 0033; 0046; 0047; 0048; 0049, (2019/06/27)
The invention provides a novel anticancer compound. The novel anticancer compound is a compound shown in chemical formula 1 in the description or pharmaceutically acceptable salt of the compound, andthe compound and the salt are active ingredients of a pharmaceutical composition for inhibiting the activity of hepatocyte growth factor receptor (c-Met) tyrosine kinase and pharmaceutical compositionfor preventing or curing excessive or abnormal proliferative diseases. The compound effectively inhibits the activity of the hepatocyte growth factor receptor tyrosine kinase, thereby being suitablefor treating the diseases with the characteristics of excessive or abnormal cell proliferation.
